Asset Dedication’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Asset Dedication's AZN Position: Q3 2026 in Review
Asset Dedication reduced its AstraZeneca (AZN) stake by 7.6% in Q3 2026, selling an estimated $15.7K and leaving 1,150 shares worth $186K. The position accounts for 0.01% of the portfolio, ranked #332.
Asset Dedication first reported a position in AZN in Q4 2019 and has held it in 13 quarters since. The position peaked at $271K in Q4 2025. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Asset Dedication held 1,150 shares of AstraZeneca worth $186K as of Q3 2026.
- Asset Dedication sold 94 AstraZeneca shares in Q3 2026, an estimated $15.7K.
- AstraZeneca made up 0.01% of Asset Dedication's portfolio in Q3 2026, its #332 holding.
- Asset Dedication first reported a position in AstraZeneca in Q4 2019 and has held it in 13 quarters since.
- Asset Dedication's AstraZeneca position peaked at $271K in Q4 2025.
- 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.